[1] 吴明山,刘振球,陈兴栋,等.全球乙型肝炎病毒基因型的分布现状.中华疾病控制杂志,2020,24(2):217-221. [2] Wang Y, Du Z, Lawrence WR, et al. Predictinghepatitis B virus infection based on health examination data of community population. Int J Environ Res Public Health, 2019, 16(23):4842-4854. [3] Tan M, Bhadoria AS, Cui F, et al. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2021, 6(2):106-119. [4] Liu Z, Derkach A, Yu KJ, et al. Patterns ofhuman leukocyte antigen class I and class II associations and cancer. Cancer Res, 2021, 81(4):1148-1152. [5] Wang T, Shen C, Qi J, et al. Haplotype-dependent HLA-DRB1-DQB1 susceptibility to occult HBV infection in Xi'an Han population. Mol Genet Genomic Med, 2023, 11(4):2102-2110. [6] 熊印祥,宦丽君,刘巧.代谢相关脂肪性肝病患者SLCO1B1和APOE基因多态性与脂代谢紊乱关系研究.实用肝脏病杂志,2023,26(2):206-209. [7] Gomaa HE, Mahmoud M, Saad NE, et al. Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients. J Genet Eng Biotechnol, 2018, 16(1):47-51. [8] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2022年版).实用肝脏病杂志,2023,26(3)S18-39. [9] 张磊,郑芳.载脂蛋白E基因分型方法学进展及其临床意义.中华检验医学杂志,2018,41(12):963-967. [10] Chu YJ, Yang HI, Hu HH, et al. HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patients. Sci Rep, 2023, 13(1):359-367. [11] Li D, Zeng Z, Zhao S, et al. Human leukocyte antigen polymorphism HLA-A*24:02 is associated with acute liver disease in HBV-infected Han Chinese adults. Immunol Invest, 2023, 52(6):767-778. [12] Zongo SV, Djigma FW, Yonli AT, et al. Association of DRB1*11 andDRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso. Mol Biol Rep, 2023, 50(6):5039-5047. [13] Huang YH, Liao SF, Khor SS, et al. Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Aliment Pharmacol Ther, 2020, 52(4):682-691. [14] Matei HV, Vica ML, Siserman CV. Association between HLA class II alleles and hepatitis B virus infection in Transylvania, Romania. Immunol Invest, 2018, 47(7):735-744. [15] Akcay IM, Katrinli S, Ozdil K, et al. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol, 2018, 24(30):3347-3360. [16] Karrar A, Hariharan S, Fazel Y, et al. Analysis of human leukocyte antigen allele polymorphism in patients with nonalcoholic fatty liver disease. Medicine (Baltimore), 2019, 98(32):e16704. [17] 罗丽,王晓东,祁海滨,等.ApoE基因多态性与肥胖儿童肺炎支原体感染及反复呼吸道感染的关系.中华医院感染学杂志,2021,31(14):2224-2227. [18] Linard M, Letenneur L, Garrigue I, et al. Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease. Alzheimers Dement, 2020, 16(1):200-208. [19] Ojeda-Granados C, Panduro A, Gonzalez-Aldaco K, et al. Adherence to afish-rich dietary pattern is associated with chronic hepatitis C patients showing low viral load: implications for nutritional management. Nutrients, 2021, 13(10):3337-3351. [20] Brito-Marques PR, Rocha-Filho PAS, Dellalibera E, et al. Cognitive changes in patient living with HIV-AIDS and apolipoprotein-Epolymorphism: is there an association? Mol Biol Rep, 2020, 47(11):8757-8762. [21] Nascimento JCR, Pereira LC, Rêgo JMC, et al. Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis. World J Gastroenterol, 2021, 27(11):1064-1075. [22] Tréguier Y, Bull-Maurer A, Roingeard P. Apolipoprotein E, acrucial cellular protein in the lifecycle of hepatitis viruses. Int J Mol Sci, 2022, 23(7):3676-3687. [23] Hemeda AA, Ahmad Mohamed A, Aziz RK, et al. Impact of IL10, MTP, SOD2, and APOEgene polymorphisms on the severity of liver fibrosis induced by HCV genotype 4. Viruses, 2021, 13(4):714-731. |